Solving Challenges Caused by COVID-19
A new survey of pharma executives shows that COVID-19 created clinical trial delays across therapeutic areas, mainly because CRAs and patients couldn’t get to sites.
To solve this, many pharma companies are seeking advanced data collection and analytics capabilities:
- 27.98% want remote monitoring
- 62.61% want integrated data
- 69.63% of people working on COVID-19 trials want integrated data